These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25399549)

  • 1. Investigating dynamic structural and mechanical changes of neuroblastoma cells associated with glutamate-mediated neurodegeneration.
    Fang Y; Iu CY; Lui CN; Zou Y; Fung CK; Li HW; Xi N; Yung KK; Lai KW
    Sci Rep; 2014 Nov; 4():7074. PubMed ID: 25399549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?
    Beal MF
    Ann Neurol; 1992 Feb; 31(2):119-30. PubMed ID: 1349466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of glutamate-dependent neurodegeneration in ischemia and traumatic brain injury.
    Arundine M; Tymianski M
    Cell Mol Life Sci; 2004 Mar; 61(6):657-68. PubMed ID: 15052409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in N-methyl-D-aspartate receptor sensitivity and magnesium blockade occur early in development in the R6/2 mouse model of Huntington's disease.
    Starling AJ; André VM; Cepeda C; de Lima M; Chandler SH; Levine MS
    J Neurosci Res; 2005 Nov; 82(3):377-86. PubMed ID: 16211559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible cellular mechanism accounting for the cell type-specific vulnerability in Huntington's disease.
    Centonze D; Giacomini P; Tolu M; Bernardi G; Calabresi P
    Funct Neurol; 2000; 15(4):253-8. PubMed ID: 11213528
    [No Abstract]   [Full Text] [Related]  

  • 6. Attenuation of low dose methylmercury and glutamate induced-cytotoxicity and tau phosphorylation by an N-methyl-D-aspartate antagonist in human neuroblastoma (SHSY5Y) cells.
    Petroni D; Tsai J; Mondal D; George W
    Environ Toxicol; 2013 Dec; 28(12):700-6. PubMed ID: 21976409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate-based therapeutic approaches: NR2B receptor antagonists.
    Gogas KR
    Curr Opin Pharmacol; 2006 Feb; 6(1):68-74. PubMed ID: 16376149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer's disease.
    Hynd MR; Scott HL; Dodd PR
    Neurochem Int; 2004 Oct; 45(5):583-95. PubMed ID: 15234100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutamate N-methyl-D-aspartate and dopamine receptors have contrasting effects on the limbic versus the somatosensory cortex with respect to amphetamine-induced neurodegeneration.
    Bowyer JF; Delongchamp RR; Jakab RL
    Brain Res; 2004 Dec; 1030(2):234-46. PubMed ID: 15571672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease.
    Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I
    Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of functional NR1/NR2B-type NMDA receptors in neuronally differentiated SK-N-SH human cell line.
    Pizzi M; Boroni F; Bianchetti A; Moraitis C; Sarnico I; Benarese M; Goffi F; Valerio A; Spano P
    Eur J Neurosci; 2002 Dec; 16(12):2342-50. PubMed ID: 12492429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections.
    Danysz W; Parsons CG
    Br J Pharmacol; 2012 Sep; 167(2):324-52. PubMed ID: 22646481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high glutamate concentrations on mitochondria of human neuroblastoma SH-SY5Y cells.
    Dubey Tiwari K; Sharma G; Prakash MM; Parihar MS; Dawane V
    Ann Pharm Fr; 2023 May; 81(3):457-465. PubMed ID: 36252868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NR1 and GluR2 expression mediates excitotoxicity in chronic hypobaric hypoxia.
    Hota SK; Barhwal K; Singh SB; Sairam M; Ilavazhagan G
    J Neurosci Res; 2008 Apr; 86(5):1142-52. PubMed ID: 17969105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of
    Park JS; Kim T; Kim D; Jeong YI
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motor impairments, striatal degeneration, and altered dopamine-glutamate interplay in mice lacking PSD-95.
    Zhang J; Saur T; Duke AN; Grant SG; Platt DM; Rowlett JK; Isacson O; Yao WD
    J Neurogenet; 2014; 28(1-2):98-111. PubMed ID: 24702501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis.
    Harkany T; Abrahám I; Timmerman W; Laskay G; Tóth B; Sasvári M; Kónya C; Sebens JB; Korf J; Nyakas C; Zarándi M; Soós K; Penke B; Luiten PG
    Eur J Neurosci; 2000 Aug; 12(8):2735-45. PubMed ID: 10971616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New targets for pharmacological intervention in the glutamatergic synapse.
    Gardoni F; Di Luca M
    Eur J Pharmacol; 2006 Sep; 545(1):2-10. PubMed ID: 16831414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Glutamate and NMDA Receptors in Alzheimer's Disease.
    Wang R; Reddy PH
    J Alzheimers Dis; 2017; 57(4):1041-1048. PubMed ID: 27662322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective neuronal degeneration in Huntington's disease.
    Cowan CM; Raymond LA
    Curr Top Dev Biol; 2006; 75():25-71. PubMed ID: 16984809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.